Posted on 7/23/20
Column Health Acquires Center for Psychiatric Medicine (CPM) in Lawrence, MA
BOSTON--(BUSINESS WIRE)--Column Health, a network of comprehensive, technology-enabled, community-based outpatient mental health and addiction clinics located throughout Massachusetts and Connecticut, announces the acquisition of the Center . . .
Posted on 7/23/20
MariMed Announces Debt Restructuring Actions and Improved Revenues and Cash Flow
NORWOOD, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (the “Company” or MariMed), a leading multi-state cannabis and hemp operator focused on health . . .
Posted on 7/23/20
Genocea Provides Second Quarter 2020 Corporate Update
CAMBRIDGE, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today reported its operating and financial . . .
Posted on 7/23/20
How Thermo Fisher Scientific Trounced Q2 Earnings Estimates
Thermo Fisher Scientific (NYSE:TMO) has turned what seemed like a horrible year into a very good one. Its shares were down 25% year to date at . . .
Posted on 7/23/20
Biogen Beats Second-Quarter Expectations
Shares of Biogen (NASDAQ:BIIB) hardly moved following the release of second-quarter earnings results that beat Wall Street's expectations on the top and bottom lines.Revenue rose 1.7% . . .
Posted on 7/22/20
Lexington Medical and BOWA Medical Announce Commercial Partnership
BILLERICA, Mass. & GOMARINGEN, Germany--(BUSINESS WIRE)--Lexington Medical, a US-based medical device company delivering minimally-invasive surgical stapling solutions, and BOWA Medical, a leading innovator of energy based . . .
Posted on 7/22/20
Genocea Announces Private Placement Financing of Up to $80 Million
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it has entered into a private placement led by an undisclosed leading
Posted on 7/22/20
Vesigen Therapeutics Launches with $28.5M Series A
Vesigen Therapeutics launched today with the objective to overcome the hurdle of targeted intracellular drug delivery of next-generation therapeutics, such as CRISPR-cas9,
Posted on 7/22/20
Thermo Fisher Scientific Reports Second Quarter 2020 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 27, 2020.Second Quarter . . .
Posted on 7/22/20
IPO Update: iTeos Therapeutics Finalizes IPO Plan
SummaryiTeos Therapeutics has filed to raise $151 million from an IPO of its common stock.The firm is developing treatments for solid tumors and other high prevalence . . .
Posted on 7/21/20
Relay Therapeutics Closes IPO
CAMBRIDGE, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled . . .
Posted on 7/21/20
Translate Bio Closes Expanded Collaboration and Licensing Agreement with Sanofi Pasteur
LEXINGTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative . . .
Posted on 7/21/20
Baystate Health and Kindred Healthcare Announce Planned Joint Venture Behavioral Health Hospital in Western Massachusetts
SPRINGFIELD, Mass. & LOUISVILLE, Ky.--(BUSINESS WIRE)--Baystate Health and Kindred Healthcare, LLC today announced plans to form a joint venture that will build and operate a $43 . . .
Posted on 7/21/20
Jnana Therapeutics Enters Collaboration with Roche
BOSTON--(BUSINESS WIRE)--Jnana Therapeutics today announced a strategic, multi-target collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) for the discovery of small molecule drugs . . .
Posted on 7/21/20
Collegium Pharmaceuticals - Whether It's Too Cheap
SummaryCollegium unfortunately had to cut the 2020 guidance in a small way alongside first quarter earnings report.Despite this shortfall, I still peg adjusted earnings around $3 . . .
Posted on 7/21/20
IPO Update: Inozyme Pharma Readies IPO Effort
SummaryInozyme Pharma has filed to raise $75 million in a U.S. IPO.The firm is developing treatments for abnormal calcification conditions.INZY is still at a very early . . .
Posted on 7/21/20
Can Berkshire Hathaway Join the $1 Trillion Club?
In the 56 years since Warren Buffett took over a struggling textile manufacturer called Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B), the company has been one of the biggest investment . . .
Posted on 7/20/20
Proper Nutrition, Starting with Daily Celery Juice, is Key to Building Healthy Immune System
Sally Ridgely Thompson Sally Ridgely Thompson doesn’t get those long, quizzical stares from the cashiers at the Whole Foods Market at Mt. Washington any longer because, . . .
Posted on 7/20/20
SFL Scientific Named Partner of the Year for AI Services Delivery by NVIDIA
BOSTON--(BUSINESS WIRE)--SFL Scientific today announced that it has been selected by the NVIDIA Partner Network (NPN) as the 2019 Service Delivery Partner of the Year 2019 . . .
Posted on 7/20/20
Collective Medical and Fallon Health Announce Partnership
SALT LAKE CITY--(BUSINESS WIRE)--Collective Medical, delivering the leading ADT-based network for real-time care collaboration, today announced a partnership with Fallon Health, a nationally recognized not-for-profit health . . .
Posted on 7/20/20
Karyopharm Is Trading At A Discount After Recent Additional Xpovio Approval
SummaryKaryopharm has a market cap under $1.5 billion, yet peak sales of Xpovio in just its first 3 indications could easily exceed that figure.The company has . . .
Posted on 7/20/20
Is Moderna Close to Winning the Coronavirus Vaccine Race?
Moderna (NASDAQ:MRNA) has taken another step closer to making its dream of commercializing a coronavirus vaccine a reality. The company just released more detailed interim results . . .
Posted on 7/19/20
Frequency Therapeutics Announces $42M Private Placement
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a . . .
Posted on 7/19/20
BioSig Technologies Adopts Stockholder Rights Agreement
Westport, CT, July 16, 2020 (GLOBE NEWSWIRE) --BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve . . .
Posted on 7/19/20
Pandion Therapeutics Prices IPO
WATERTOWN, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- Pandion Therapeutics, Inc. (Nasdaq: PAND), a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs . . .
Boston
